RTW Investments’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.2M	Sell	13,680,248 -2,718,049	-17%	-$12.6M	0.61%	40
2025 Q4	$90.2M	Sell	16,398,297 -7,955,994	-33%	-$38.6M	0.9%	30
2025 Q3	$79.6M	Sell	24,354,291 -667,293	-3%	-$1.89M	0.98%	29
2025 Q2	$57.8M	Buy	25,021,584 +6,233,718	+33%	+$13.5M	0.82%	33
2025 Q1	$26.1M	Buy	18,787,866 +10,115,236	+117%	+$16.9M	0.4%	38
2024 Q4	$15M	Sell	8,672,630 -6,273,790	-42%	-$13M	0.23%	49
2024 Q3	$30M	Sell	14,946,420 -3,853,879	-20%	-$8.46M	0.43%	40
2024 Q2	$42.1M	Buy	18,800,299 +207,114	+1%	+$603K	0.65%	37
2024 Q1	$53.4M	Buy	18,593,185 +1,700,000	+10%	+$3.54M	0.79%	38
2023 Q4	$29.9M	Hold	16,893,185	–	–	0.47%	36
2023 Q3	$53.4M	Buy	+16,893,185	New	+$31.6M	1.13%	23